Macrogenics (MGNX) Other Non Operating Income (2012 - 2026)
Macrogenics (MGNX) reported Other Non Operating Income of $1.6 million for Q1 2026, down 7.44% year-over-year from $1.7 million in Q1 2025, and up 8.14% quarter-over-quarter from $1.4 million in Q4 2025.
Macrogenics (MGNX) Other Non Operating Income (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Other Non Operating Income data on file, last reported at $1.6 million in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $1.6 million, down 7.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.9 million (down 29.42% YoY), and the FY2025 annual result was $6.1 million, down 35.71% from the prior year.
- Other Non Operating Income improved to $1.6 million in Q1 2026 per MGNX's latest filing, from $1.4 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $3.3 million in Q4 2023 and troughed at $142000.0 in Q3 2022.
- A 5-year average of $1.7 million and a median of $1.6 million in 2026 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income soared 2052.11% in 2023, then plunged 43.96% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $819000.0 in 2022, then surged by 300.73% to $3.3 million in 2023, then sank by 36.44% to $2.1 million in 2024, then sank by 31.11% to $1.4 million in 2025, then rose by 8.14% to $1.6 million in 2026.
- Business Quant data shows MGNX's Other Non Operating Income at $1.6 million in Q1 2026, $1.4 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 2.12 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 2.69 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 819,000.00 |
| Sep 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 504,000.00 |
| Mar 31, 2022 | 195,000.00 |
| Dec 31, 2021 | 214,000.00 |
| Sep 30, 2021 | 101,000.00 |
| Jun 30, 2021 | 344,000.00 |